CMS Makes Headway Toward Part B Drug Price Substitutions
Executive Summary
CMS might finally be able to use the Medicare Part B drug price substitution authority provided in the Medicare Modernization Act of 2003, due to the combined effect of the recent redefinition of average manufacturer price for drugs and the proposed Medicare physician fee schedule rule for 2011
You may also be interested in...
Part B Hospital Drug Reimbursement Set At ASP Plus 5 Percent In Final Rule
CMS had proposed an increase to ASP plus 6% for drugs used in the hospital outpatient setting in draft rule. Agency also is not moving ahead on Part B price substitution plan for drugs used in the physician office setting.
Part B Hospital Drug Reimbursement Set At ASP Plus 5 Percent In Final Rule
CMS had proposed an increase to ASP plus 6% for drugs used in the hospital outpatient setting in draft rule. Agency also is not moving ahead on Part B price substitution plan for drugs used in the physician office setting.
Drug Makers Must Continue AMP Medicaid Calculations, Despite Court Ruling
Dec. 19 federal court injunction bars CMS from publishing AMP data for now.